Company Bone Biologics Corporation

Equities

BBLG

US0980705018

Medical Equipment, Supplies & Distribution

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Devices & Implants

Market Closed - Nasdaq Other stock markets 21:00:00 16/05/2024 BST			5-day change	1st Jan Change
2.2 ^USD	-3.08%		+22.22%	-51.33%

05-04	Certain Common Stock of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	CI
05-04	Certain Warrants of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	CI

Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Number of employees: 2

Managers	Title	Age	Since
Jeffrey Frelick CEO	Chief Executive Officer	59	16/08/15
Deina Walsh DFI	Director of Finance/CFO	60	31/10/14

Members of the board	Title	Age	Since
Bruce Stroever BRD	Director/Board Member	75	31/12/11
Don Hankey CHM	Chairman	81	15/07/18
Robert Gagnon BRD	Director/Board Member	49	01-07
Siddhesh Angle BRD	Director/Board Member	39	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,100,489	807,486 ( 73.38 %)	0	73.38 %

Name	Equities	%	Valuation
Intracoastal Capital LLC 4.519 %	39,733	4.519 %	60 394 $
Armistice Capital LLC 4.208 %	37,000	4.208 %	56 240 $
Sabby Management LLC 1.123 %	9,877	1.123 %	15 013 $
Tower Research Capital LLC 0.4834 %	4,250	0.4834 %	6 460 $
Jeffrey Frelick 0.2447 %	2,151	0.2447 %	3 270 $
UBS Securities LLC 0.0682 %	600	0.0682 %	912 $
Wells Fargo Bank NA 0.000455 %	4	0.000455 %	6 $
Robert Gagnon 0.000000 %	0	0.000000 %	- $
Deina Walsh 0.000000 %	0	0.000000 %	- $
The Lind Partners LLC 0.000000 %	0	0.000000 %	- $

Name	Equities	%	Valuation
Citadel Securities GP LLC -	33,037	-	449 799 $
BofA Securities, Inc. -	100	-	1 362 $
Clear Street LLC -	100	-	1 362 $

Bone Biologics Corp.

2 Burlington Woods Drive Suite 100

01803, Burlington

http://www.bonebiologics.com

address Bone Biologics Corporation(BBLG)

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
BONE BIOLOGICS CORPORATION	-51.33%	2M
STRYKER CORPORATION	+11.57%	126B
SMITH & NEPHEW PLC	-4.96%	11.27B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+3.22%	9.12B
GLAUKOS CORPORATION	+38.90%	5.61B
INSPIRE MEDICAL SYSTEMS, INC.	-21.83%	4.75B
AXONICS, INC.	+8.74%	3.45B
ENOVIS CORPORATION	-6.82%	2.89B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-13.32%	2.07B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-6.99%	2.05B

Medical Devices & Implants